AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Headline
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…
Headline
An FBI alert released Sept. 1 warns of cyber actors impersonating government officials, media and other public individuals on a commercial messaging app to…
Headline
The AHA is now accepting applications for the new 2027 Carolyn Boone Lewis Award for Improving Health Outcomes, which recognizes hospitals and health systems’…
Headline
Clint Pridgen, vice president of business development and hospital strategy at Laerdal Medical, explores the future of healthcare simulation, including data-…
Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…
Headline
The Food and Drug Administration has identified Class I recalls of the following products: Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits and…